Drug targets and mechanisms of resistance in the anaerobic protozoa
- PMID: 11148007
- PMCID: PMC88967
- DOI: 10.1128/CMR.14.1.150-164.2001
Drug targets and mechanisms of resistance in the anaerobic protozoa
Abstract
The anaerobic protozoa Giardia duodenalis, Trichomonas vaginalis, and Entamoeba histolytica infect up to a billion people each year. G. duodenalis and E. histolytica are primarily pathogens of the intestinal tract, although E. histolytica can form abscesses and invade other organs, where it can be fatal if left untreated. T. vaginalis infection is a sexually transmitted infection causing vaginitis and acute inflammatory disease of the genital mucosa. T. vaginalis has also been reported in the urinary tract, fallopian tubes, and pelvis and can cause pneumonia, bronchitis, and oral lesions. Respiratory infections can be acquired perinatally. T. vaginalis infections have been associated with preterm delivery, low birth weight, and increased mortality as well as predisposing to human immunodeficiency virus infection, AIDS, and cervical cancer. All three organisms lack mitochondria and are susceptible to the nitroimidazole metronidazole because of similar low-redox-potential anaerobic metabolic pathways. Resistance to metronidazole and other drugs has been observed clinically and in the laboratory. Laboratory studies have identified the enzyme that activates metronidazole, pyruvate:ferredoxin oxidoreductase, to its nitroso form and distinct mechanisms of decreasing drug susceptibility that are induced in each organism. Although the nitroimidazoles have been the drug family of choice for treating the anaerobic protozoa, G. duodenalis is less susceptible to other antiparasitic drugs, such as furazolidone, albendazole, and quinacrine. Resistance has been demonstrated for each agent, and the mechanism of resistance has been investigated. Metronidazole resistance in T. vaginalis is well documented, and the principal mechanisms have been defined. Bypass metabolism, such as alternative oxidoreductases, have been discovered in both organisms. Aerobic versus anaerobic resistance in T. vaginalis is discussed. Mechanisms of metronidazole resistance in E. histolytica have recently been investigated using laboratory-induced resistant isolates. Instead of downregulation of the pyruvate:ferredoxin oxidoreductase and ferredoxin pathway as seen in G. duodenalis and T. vaginalis, E. histolytica induces oxidative stress mechanisms, including superoxide dismutase and peroxiredoxin. The review examines the value of investigating both clinical and laboratory-induced syngeneic drug-resistant isolates and dissection of the complementary data obtained. Comparison of resistance mechanisms in anaerobic bacteria and the parasitic protozoa is discussed as well as the value of studies of the epidemiology of resistance.
Figures
Similar articles
-
In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.J Eukaryot Microbiol. 2002 May-Jun;49(3):201-8. doi: 10.1111/j.1550-7408.2002.tb00523.x. J Eukaryot Microbiol. 2002. PMID: 12120985
-
Drug susceptibility testing of anaerobic protozoa.Antimicrob Agents Chemother. 2001 Jun;45(6):1810-4. doi: 10.1128/AAC.45.6.1810-1814.2001. Antimicrob Agents Chemother. 2001. PMID: 11353630 Free PMC article.
-
Keto-acid oxidoreductases in the anaerobic protozoa.J Eukaryot Microbiol. 1999 Jul-Aug;46(4):447-9. doi: 10.1111/j.1550-7408.1999.tb04628.x. J Eukaryot Microbiol. 1999. PMID: 10461388 Review.
-
In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.J Antimicrob Chemother. 2002 Jan;49(1):103-11. doi: 10.1093/jac/49.1.103. J Antimicrob Chemother. 2002. PMID: 11751773
-
Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.Future Med Chem. 2009 Jul;1(4):619-43. doi: 10.4155/fmc.09.59. Future Med Chem. 2009. PMID: 21426030 Review.
Cited by
-
Biochemistry and evolution of anaerobic energy metabolism in eukaryotes.Microbiol Mol Biol Rev. 2012 Jun;76(2):444-95. doi: 10.1128/MMBR.05024-11. Microbiol Mol Biol Rev. 2012. PMID: 22688819 Free PMC article. Review.
-
Molecular dynamics simulations of Trichomonas vaginalis ferredoxin show a loop-cap transition.Biophys J. 2007 May 15;92(10):3337-45. doi: 10.1529/biophysj.106.088096. Epub 2007 Feb 26. Biophys J. 2007. PMID: 17325017 Free PMC article.
-
Pyridyl Methylsulfinyl Benzimidazole Derivatives as Promising Agents against Giardia lamblia and Trichomonas vaginalis.Molecules. 2022 Dec 14;27(24):8902. doi: 10.3390/molecules27248902. Molecules. 2022. PMID: 36558035 Free PMC article.
-
Pathema: a clade-specific bioinformatics resource center for pathogen research.Nucleic Acids Res. 2010 Jan;38(Database issue):D408-14. doi: 10.1093/nar/gkp850. Epub 2009 Oct 20. Nucleic Acids Res. 2010. PMID: 19843611 Free PMC article.
-
Conserved metabolic enzymes as vaccine antigens for giardiasis.PLoS Negl Trop Dis. 2022 Apr 25;16(4):e0010323. doi: 10.1371/journal.pntd.0010323. eCollection 2022 Apr. PLoS Negl Trop Dis. 2022. PMID: 35468132 Free PMC article.
References
-
- Alderete J F, Lehker M W, Arroyo R. The mechanisms and molecules involved in cytoadherence and pathogenesis of Trichomonas vaginalis. Parasitol Today. 1995;11:70–74.
-
- Andersson D I, Levin B R. The biological cost of antibiotic resistance. Curr Opin Microbiol. 1999;2:489–493. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources